Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1756-9966

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies ; volume:29 ; number:1 ; day:28 ; month:12 ; year:2010 ; pages:1-9 ; date:12.2010
Journal of experimental & clinical cancer research ; 29, Heft 1 (28.12.2010), 1-9, 12.2010

Creator: Ben Jemaa, Awatef
Bouraoui, Yosra
Sallami, Sataa
Banasr, Ahmed
Rais, Nawfel Ben
Ouertani, Latifa
Nouira, Yassin
Horchani, Ali
Oueslati, Ridha

Contributor: SpringerLink (Online service)

DOI: 10.1186/1756-9966-29-171

URN: urn:nbn:de:101:1-2021081420473531538805

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Ben Jemaa, Awatef
Bouraoui, Yosra
Sallami, Sataa
Banasr, Ahmed
Rais, Nawfel Ben
Ouertani, Latifa
Nouira, Yassin
Horchani, Ali
Oueslati, Ridha
SpringerLink (Online service)

Other Objects (12)

The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity

Biomarkers for prostate cancer: prostate-specific antigen and beyond

Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria

Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer

Relation of Serum Prostate-Specific Antigen with Histological Features and Grading of Prostate Adenocarcinoma in Prostatic Biopsies

Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy

Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy

Extensive Metastases in Prostatic Carcinoma with Normal Prostate-Specific Antigen and Raised Carcinoembryonic Antigen – Small Cell Carcinoma of Prostate: A Rare Entity

Prostate-specific antigen-based screening: controversy and guidelines

Prostate-specific antigen testing accuracy in community practice

Prostate cancer risk prediction based on clinical factors and prostate-specific antigen

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen

The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity

Biomarkers for prostate cancer: prostate-specific antigen and beyond

Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria

Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer

Relation of Serum Prostate-Specific Antigen with Histological Features and Grading of Prostate Adenocarcinoma in Prostatic Biopsies

Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy

Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy

Extensive Metastases in Prostatic Carcinoma with Normal Prostate-Specific Antigen and Raised Carcinoembryonic Antigen – Small Cell Carcinoma of Prostate: A Rare Entity

Prostate-specific antigen-based screening: controversy and guidelines

Prostate-specific antigen testing accuracy in community practice

Prostate cancer risk prediction based on clinical factors and prostate-specific antigen

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen

The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity

Biomarkers for prostate cancer: prostate-specific antigen and beyond

Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria

Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer

Relation of Serum Prostate-Specific Antigen with Histological Features and Grading of Prostate Adenocarcinoma in Prostatic Biopsies

Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy

Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy

Extensive Metastases in Prostatic Carcinoma with Normal Prostate-Specific Antigen and Raised Carcinoembryonic Antigen – Small Cell Carcinoma of Prostate: A Rare Entity

Prostate-specific antigen-based screening: controversy and guidelines

Prostate-specific antigen testing accuracy in community practice

Prostate cancer risk prediction based on clinical factors and prostate-specific antigen

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity

Biomarkers for prostate cancer: prostate-specific antigen and beyond

Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria

Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer

Relation of Serum Prostate-Specific Antigen with Histological Features and Grading of Prostate Adenocarcinoma in Prostatic Biopsies

Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy

Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy

Extensive Metastases in Prostatic Carcinoma with Normal Prostate-Specific Antigen and Raised Carcinoembryonic Antigen – Small Cell Carcinoma of Prostate: A Rare Entity

Prostate-specific antigen-based screening: controversy and guidelines

Prostate-specific antigen testing accuracy in community practice

Prostate cancer risk prediction based on clinical factors and prostate-specific antigen

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen

The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity

Biomarkers for prostate cancer: prostate-specific antigen and beyond

Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria

Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer

Relation of Serum Prostate-Specific Antigen with Histological Features and Grading of Prostate Adenocarcinoma in Prostatic Biopsies

Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy

Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy

Extensive Metastases in Prostatic Carcinoma with Normal Prostate-Specific Antigen and Raised Carcinoembryonic Antigen – Small Cell Carcinoma of Prostate: A Rare Entity

Prostate-specific antigen-based screening: controversy and guidelines

Prostate-specific antigen testing accuracy in community practice

Prostate cancer risk prediction based on clinical factors and prostate-specific antigen

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen

The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity

Biomarkers for prostate cancer: prostate-specific antigen and beyond

Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria

Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer

Relation of Serum Prostate-Specific Antigen with Histological Features and Grading of Prostate Adenocarcinoma in Prostatic Biopsies

Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy

Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy

Extensive Metastases in Prostatic Carcinoma with Normal Prostate-Specific Antigen and Raised Carcinoembryonic Antigen – Small Cell Carcinoma of Prostate: A Rare Entity

Prostate-specific antigen-based screening: controversy and guidelines

Prostate-specific antigen testing accuracy in community practice

Prostate cancer risk prediction based on clinical factors and prostate-specific antigen

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen

Related objects

Reset password